Skip to content

Impact of Perioperative Nutritional Status and Management in the Context of Resectable Pancreatic Adenocarcinoma

Impact of Perioperative Nutritional Status and Management in the Context of Resectable Pancreatic Adenocarcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06893536
Acronym
PAAD
Enrollment
100
Registered
2025-03-25
Start date
2023-10-12
Completion date
2025-10-12
Last updated
2025-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Adenocarcinoma

Keywords

Pancreatic Adenocarcinoma, Digestive tract, Hypercatabolism, Malnutrition,

Brief summary

Patients with pancreatic adenocarcinoma are frequently in a situation of malnutrition, in a context of functional alteration of the digestive tract, and hypercatabolism. As a result, nutritional support is frequently necessary perioperatively, but currently does not follow a specific protocol, and without coordination. It then appears the need to evaluate the prevalence of malnutrition, its impact on perioperative morbidity and mortality, and current management methods. Depending on the findings, subsequent interventional studies will be carried out on the subject, exploring the different modalities of artificial nutrition.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Major subject (≥18 years old) * Subject with pancreatic adenocarcinoma authenticated by pathology * Subject candidate for curative surgical treatment * Subject operated on in the visceral and digestive surgery department, NHC Strasbourg, during the period from January 1, 2018 to December 31, 2022 * Absence of written opposition in the subject's medical file to the reuse of their data for scientific research purposes.

Exclusion criteria

* Subject having expressed opposition to participating in the study * Subject presenting a metastatic form or one not accessible to surgical treatment considered curative of pancreatic adenocarcinoma * Subject under guardianship or curatorship * Subje

Design outcomes

Primary

MeasureTime frameDescription
Study of the Severity of Perioperative Malnutrition in Pancreatic AdenocarcinomaUp to 1 yearThe CCI score measures a patient's postoperative outcome based on the number and severity of complications occurring on a scale of 0 to 100: 0: No complications 100: Death

Countries

France

Contacts

Primary ContactZineb CHERKAOUI, MD
zineb.cherkaoui@chru-strasbourg.fr33 3 69 55 13 15

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026